Arctic Bioscience AS (DE:9TD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Eggesbø Eiendom AS, associated with Arctic Bioscience board member Per Magne Eggesbø, sold its entire holding of 520,240 shares in the company at NOK 2.23 each. Arctic Bioscience, known for its marine-based pharmaceuticals and nutraceuticals, is developing a novel oral drug for psoriasis treatment. This transaction highlights movement within the company’s shareholder base, potentially impacting investor sentiment.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
